Literature DB >> 12694584

Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.

K Yoshizawa1, M Ota, S Saito, A Maruyama, T Yamaura, A Rokuhara, K Orii, T Ichijo, A Matsumoto, E Tanaka, K Kiyosawa.   

Abstract

Hepatitis C virus (HCV) causes various grades of chronic liver disease, ranging from an asymptomatic state to cirrhosis. To assess genetic factors of disease severity, we selected two HCV patient groups according to the following stringent criteria: (i) asymptomatic carrier state (ASC) defined by HCV infection for more than 20 years, normal alanine aminotransferase levels for the past 5 years as well as normal liver histology and/or shape and (ii) liver cirrhosis (LC) as diagnosed by clinical symptoms, liver biopsy and/or ultrasonography. A total of 103 chronically infected Japanese HCV patients (43 ASC and 60 LC) were analyzed. HLA class I and II alleles were established using low resolution DNA typing. HLA-DRB1 and DQB1 genotypes were inferred upon polymerase chain reaction-restriction fragment length polymorphism analysis. Two hundred and one anti-HCV-negative ethnically matched controls were included. The frequencies of DRB1*12 (*1201 and *1202), DQB1*0301 and DRB3*03 alleles were higher in patients with ASC than in those with LC (odds ratio (OR) 11.23, OR 4.25, and OR 3.22, respectively). The frequency of DQB1*0503 were lower in ASC patients compared to LC patients (OR 0.05). No significant differences between groups were observed for age, sex, source of infection, HCV genotype or viral loads. Our findings establish that certain HLA class II alleles strongly influence disease progression following HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694584     DOI: 10.1034/j.1399-0039.2003.00015.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.

Authors:  Nadia Bouzgarrou; Elham Hassen; Olfa Bahri; Sallouha Gabbouj; Nabil Ben Mami; Henda Triki; Lotfi Chouchane
Journal:  Hepatol Int       Date:  2011-02-08       Impact factor: 6.047

2.  The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

Review 3.  Host genetic factors and antiviral immune responses to hepatitis C virus.

Authors:  Chloe L Thio
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 4.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 5.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

6.  Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepat Res Treat       Date:  2011-06-14

7.  Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population.

Authors:  Ming Yue; Ke Xu; Meng-Ping Wu; Ya-Ping Han; Peng Huang; Zhi-Hang Peng; Jie Wang; Jing Su; Rong-Bin Yu; Jun Li; Yun Zhang
Journal:  Int J Mol Sci       Date:  2015-07-23       Impact factor: 5.923

8.  HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study.

Authors:  Daiki Miki; Hidenori Ochi; Atsushi Takahashi; C Nelson Hayes; Yuji Urabe; Hiromi Abe; Tomokazu Kawaoka; Masataka Tsuge; Nobuhiko Hiraga; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Shoichi Takahashi; Norio Akuta; Fumitaka Suzuki; Kenji Ikeda; Hiromitsu Kumada; Yoshiyasu Karino; Joji Toyota; Tatsuhiko Tsunoda; Michiaki Kubo; Naoyuki Kamatani; Yusuke Nakamura; Kazuaki Chayama
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.